Table 2. The enriched KEGG pathway with differentially expressed genes (P<0.001).
Pathway ID | Pathway name | Count | Fold enrichment | P-value |
---|---|---|---|---|
rno04932 | NAFLD | 14 | 6.003 | 4.39 × 10−7 |
rno04260 | Cardiac muscle contraction | 10 | 8.905 | 1.42 × 10−6 |
rno01100 | Metabolic pathways | 39 | 2.095 | 4.16 × 10−6 |
rno00190 | Oxidative phosphorylation | 12 | 5.7889 | 5.79 × 10−6 |
rno05012 | Parkinson’s disease | 12 | 5.484 | 9.74 × 10−6 |
rno05010 | Alzheimer’s disease | 13 | 4.961 | 9.80 × 10−6 |
rno00640 | Propanoate metabolism | 6 | 14.885 | 4.09 × 10−5 |
rno01200 | Carbon metabolism | 10 | 5.740 | 5.27 × 10−5 |
rno00280 | Valine, leucine, and isoleucine degradation | 7 | 8.840 | 1.21 × 10−4 |
rno05016 | Huntington’s disease | 12 | 4.106 | 1.41× 10−4 |
rno01130 | Biosynthesis of antibiotics | 12 | 3.806 | 2.73 × 10−4 |